With limited research on ketamine's effectiveness against pain, some experts wor...
Longtime cancer doctor Monica Bertagnolli is finally heading to the NIH director...
The number of babies born with congenital syphilis in the U.S. has soared over t...
The FTC is challenging more than 100 patents on brand-name medicines that were i...
TLM-005 is under clinical development by Therillume and currently in Phase I for...
TLM-004 is under clinical development by Therillume and currently in Phase I for...
TLM-003 is under clinical development by Therillume and currently in Phase I for...
StromaForte is under clinical development by Swedish StromaBio and currently in ...
Fulvestrant is under clinical development by Kashiv BioSciences and currently in...
TLM-101 is under clinical development by Therillume and currently in Phase I for...
TLM-006 is under clinical development by Therillume and currently in Phase I for...
AWT-020 is under clinical development by Anwita Biosciences and currently in Pha...
StromaForte is under clinical development by Swedish StromaBio and currently in ...
StromaForte is under clinical development by Swedish StromaBio and currently in ...
Today STAT turns 8! Read a letter from our executive editor @rickberke on the mi...
A bipartisan bill would permanently extend a Covid-era policy that allowed patie...